Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |